Clinical Trials on Infections, Papillomavirus in Switzerland

Total 863 results

Regina Grossmann

Terminated

USZ BioResource COVID-19

COVID19

Switzerland
University Hospital, Geneva

Completed

Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia (PneumoCoV-Ambu)

Pneumonia | Covid19

Switzerland
Aeras
Sanofi Pasteur, a Sanofi Company

Completed

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults (C-013-404)

Tuberculosis

Switzerland
Goldhahn Jörg

Completed

Spread and Course of COVID-19 Infections (CoV-ETH)

Covid-19 | Virus Disease

Switzerland
University Hospital, Basel, Switzerland
Botnar Research Centre for Child Health

Completed

Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19

COVID-19 Disease

Switzerland
University Hospital, Basel, Switzerland

Completed

COVID-19 Survival - The COVIVA Study (COVIVA)

COVID-19 | SARS-CoV 2

Switzerland
University Hospital, Basel, Switzerland

Completed

SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting

Covid19 | SARS-CoV-2

Switzerland
Aesculap AG

Terminated

Sternal Closure With STERNUMFIX in Patients With High Risk (STEPHIX)

Sternum Wound Infection | Nonunion of Fracture of Sternum

Germany, Switzerland
University Hospital, Geneva

Recruiting

Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines (Pertagen2x)

Pertussis | Vaccine-Preventable Diseases

Switzerland
Hervé SPECHBACH
OM Pharma SA

Completed

Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19. (COVID-19)

COVID-19 Virus Disease

Switzerland
University of Zurich
PD Dr. rer. nat. Mathias Heikenwälder

Unknown

A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.

Chronic HCV Hepatitis C

Switzerland
University Hospital, Basel, Switzerland

Terminated

Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine (SASL28)

Hepatitis, Chronic

Switzerland
University of Zurich
Swiss School of Public Health (SSPH+)

Recruiting

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children (CiaoCorona)

COVID-19 | SARS-CoV 2

Switzerland
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); EuroVacc Foundation

Completed

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

HIV Infections

Switzerland
ANRS, Emerging Infectious Diseases

Terminated

Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical Trial (AMEP-EHVA T02)

HIV Seropositivity

Switzerland
GlycoVaxyn AG

Completed

Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella

Shigellosis

Switzerland
ANRS, Emerging Infectious Diseases
University College London Hospitals; Hospital Clinic of Barcelona; Imperial College... and other collaborators

Completed

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

HIV-1-infection

France, United Kingdom, Switzerland
University Hospital Inselspital, Berne
ETH Zurich

Completed

WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories (WAVE)

SARS-CoV 2 | COVID 19 | COVID

Switzerland
HIV Vaccine Trials Network

Completed

Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults

HIV Infections

Switzerland
University Hospital Inselspital, Berne

Terminated

Daptomycin in Pediatric Patients With Bacterial Meningitis

Meningitis

Switzerland
Bavarian Nordic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.

Smallpox

Switzerland
Luzerner Kantonsspital

Completed

Wound Closure (Allgower) Versus Secondary Open Wound Healing After Removal of the External Fixator (Pinsides)

Infection Rates Between Primary Wound-closure (Allgower) and Secondary Wound Healing After Removal of an External Fixator

Switzerland
University of Zurich
Swiss HIV Cohort Study

Recruiting

Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures

HIV Infections

Switzerland
Hôpital du Valais

Recruiting

Prognostic of Dysfunctional Breathing in Long Covid: a Follow up Study

COVID-19 | Dysfunctional Breathing

Switzerland
Bristol-Myers Squibb
Basel Institute of Clinical Epidemiology (BICE)

Completed

Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period

Hepatitis C

Switzerland
Pevion Biotech Ltd

Completed

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Chronic Hepatitis C

Switzerland
University Hospital, Basel, Switzerland
University of Basel; Swiss Federal Institute of Technology; University Children...

Completed

Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland

Influenza

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14)

Influenza

Switzerland
Innovative Medicines for Tuberculosis
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing

Tuberculosis, Pulmonary

Switzerland
Klara M. Pósfay Barbe
University Hospital, Geneva

Recruiting

Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients (MMRinOLT)

Measles

Switzerland
University of Zurich

Active, not recruiting

The RIsk Stratification in COVID-19 Patients in the ICU Registry (RISC-19-ICU)

COVID-19 | Critical Illness | Inflammatory Response | ARDS | Circulatory Shock

Switzerland
A. Vogel AG
University Children's Hospital, Zurich

Withdrawn

Echinaforce Junior Bioavailability Trial

Common Cold

Switzerland
Johannes Scherr

Recruiting

GRIP: Maximum Isometric Grip Strength Assessed With Three Different Hand-held Dynamometers

Grip

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains

Influenza

Switzerland
Centre Hospitalier Universitaire Vaudois
GlaxoSmithKline; University of Lausanne; University of Lausanne Hospitals; World... and other collaborators

Completed

A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

Ebola Vaccines

Switzerland
Innovative Medicines for Tuberculosis
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation

Tuberculosis | Tuberculosis, Pulmonary

Switzerland
University Hospital Inselspital, Berne

Completed

Vaginal, Oral and Systemic Inflammation in Preterm Birth

Local or Systemic Signs for Infection, Preterm Birth

Switzerland
University Hospital, Basel, Switzerland

Completed

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine (MACIS)

Myocarditis

Switzerland
Novartis Vaccines

Completed

Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines

Influenza

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
Crucell Holland BV

Completed

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
University of Zurich
Federal Office of Sports, Switzerland; Swiss Ankylosing Spondylitis Association

Completed

Effects of Cardiovascular Training in Individuals With Ankylosing Spondylitis

Ankylosing Spondylitis

Switzerland
University Hospital, Geneva

Completed

Clinical Metagenomics of Infective Endocarditis (Meta-ENDO)

Infective Endocarditis

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis

Tuberculosis

Switzerland
University Hospital, Basel, Switzerland

Completed

Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 (COVID-RT-01)

Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)

Switzerland
University of Zurich
Wroclaw Medical University

Unknown

The Global PCHF-COVICAV Registry (PCHF-COVICAV)

Cardiovascular Diseases | Heart Failure | COVID-19 | Cardiovascular Risk Factor

Switzerland
Neurotune AG

Unknown

Dimiracetam in Painful Neuropathies Affecting AIDS Patients (DIPANAP)

Acquired Immunodeficiency Syndrome

Switzerland

3

Subscribe